Choline

Choline

SCHEMBL2935374

C[N+](C)(C)CCO.[Ca+2].[Cl-].[Cl-].[Cl-]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.93
SLC5A7 Q9GZV3 1/20 0.93
MEN1 O00255 5/20 0.80
KMT2A Q03164 5/20 0.80
LMNA P02545 3/20 0.80
APEX1 P27695 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NFKB1 P19838 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ACHE P22303 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PMP22 Q01453 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
DNM1 Q05193 2/20 0.36
BLM P54132 2/20 0.36
BBOX1 O75936 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Choline SCHEMBL3265483 1.00
Choline SCHEMBL14957 0.96
Choline SCHEMBL29499824 0.96
Choline SCHEMBL28574484 0.96 CYP3A4 (1.00) CYP3A4SLC5A7MEN1KMT2ALMNA
Choline SCHEMBL1330530 0.96
Choline SCHEMBL9391204 0.96 CYP3A4 (1.00) CYP3A4SLC5A7MEN1KMT2ALMNA
Choline SCHEMBL2459999 0.96 CYP3A4 (1.00) CYP3A4SLC5A7MEN1KMT2ALMNA
Choline SCHEMBL1332010 0.96
Choline SCHEMBL30612764 0.96
Choline SCHEMBL9422358 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113816991-A Preparation method of choline calcium phosphochloride 新乡拓新药业股份有限公司 2021-12-21 CN claimed
EP-2820028-A1 A PROCESS FOR PREPARING PURE CITICOLINE (CDP-CHOLINE) Frichem Private Limited (IN) 2015-01-07 EP claimed
WO-2013128393-A1 A PROCESS FOR PREPARING PURE CITICOLINE (CDP-CHOLINE) FRICHEM PRIVATE LIMITED (IN) 2013-09-06 WO claimed
EP-2229130-A2 REMINERALIZING COMPOSITIONS AND METHODS 3M Innovative Properties Company (US) 2010-09-22 EP claimed
WO-2009076491-A2 REMINERALIZING COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-06-18 WO claimed
CN-119955879-A Method for synthesizing citicoline by biological enzyme 拓新药业集团股份有限公司 2025-05-09 CN disclosed
WO-2025024123-A1 NOVEL CITICOLINE DERIVATIVES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-30 WO disclosed
CN-113816991-B Preparation method of choline calcium chloride phosphate 拓新药业集团股份有限公司 2023-12-15 CN disclosed
CN-113816991-B Preparation method of choline calcium chloride phosphate 拓新药业集团股份有限公司 2023-12-15 CN disclosed
CN-113816991-A Preparation method of choline calcium phosphochloride 新乡拓新药业股份有限公司 2021-12-21 CN disclosed
CN-113816991-A Preparation method of choline calcium phosphochloride 新乡拓新药业股份有限公司 2021-12-21 CN disclosed
EP-2820028-A1 A PROCESS FOR PREPARING PURE CITICOLINE (CDP-CHOLINE) Frichem Private Limited (IN) 2015-01-07 EP disclosed
US-6926917-B2 Dry pet food with increased palatability and method of production NESTEC LTD. (CH) 2005-08-09 US disclosed
WO-2004034812-A1 DRY PET FOOD WITH INCREASED PALATABILITY AND METHOD OF PRODUCTION NESTEC S.A. (CH) 2004-04-29 WO disclosed
WO-2004034811-A1 INCREASED DENSITY PET FOOD PRODUCT AND METHOD OF PRODUCTION NESTEC S.A. (CH) 2004-04-29 WO disclosed
US-20040076718-A1 Dry pet food with increased palatability and method of production NESTEC, LTD. (CH) 2004-04-22 US disclosed
US-20040076715-A1 Increased density pet food product and method of production NESTEC, LTD. (CH) 2004-04-22 US disclosed
EP-0648495-B1 Cation-complexed polysaccharides HERCULES INC (US) 2000-01-05 EP disclosed
EP-0648495-A2 Cation-complexed polysaccharides HERCULES INCORPORATED (US) 1995-04-19 EP disclosed
EP-0323855-B1 Pantethine as inhibitory agent of hepatic fibrosis DAIICHI SEIYAKU CO (JP) 1994-04-13 EP disclosed